• Explore /
  • Poster
  • / Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.

Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.

Abstract Poster

Authors

null

Neesha C. Dhani

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Neesha C. Dhani , Hal W. Hirte , Julia V. Burnier , Angela Jain , Marcus O. Butler , Stephanie Lheureux , Jean Hurteau , Stephen Welch , Koji Matsuo , Michael Method , Waldo Jimenez , Carolyn Johnston , Erica Stringer , Mihaela C. Cristea , Anjali Mehta , Judy Quintos , Susie Tan , Lisa Wang , John Joseph Wright , Amit M. Oza

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Uterine Cancer

Clinical Trial Registration Number

NCT01935934

Citation

J Clin Oncol 35, 2017 (suppl; abstr 5524)

DOI

10.1200/JCO.2017.35.15_suppl.5524

Abstract #

5524

Poster Bd #

346

Abstract Disclosures

Similar Posters

First Author: Michelle Wilson

First Author: Andrea P. Myers

First Author: Mario Javier Pineda

Poster

2014 ASCO Annual Meeting

Phase II, single stage, cohort expansion study of MK-2206 in recurrent endometrial serous cancer.

Phase II, single stage, cohort expansion study of MK-2206 in recurrent endometrial serous cancer.

First Author: Panagiotis Konstantinopoulos